Clinical review: The liver in sepsis

被引:229
作者
Nesseler, Nicolas [1 ,2 ,3 ]
Launey, Yoann [1 ,2 ,3 ]
Aninat, Caroline [2 ,3 ]
Morel, Fabrice [2 ,3 ]
Malledant, Yannick [1 ,2 ,3 ]
Seguin, Philippe [1 ,2 ,3 ]
机构
[1] Hop Pontchaillou, Serv Anesthesie Reanimat 1, F-35033 Rennes, France
[2] Hop Pontchaillou, INSERM, UMR S 991, F-35033 Rennes, France
[3] Univ Rennes 1, Fac Med, F-35033 Rennes, France
关键词
CRITICALLY-ILL PATIENTS; ENTERAL NUTRITION; ORGAN DYSFUNCTION; SEPTIC SHOCK; HEPATOCELLULAR DYSFUNCTION; INTESTINAL PERMEABILITY; HEPATIC-DYSFUNCTION; INDOCYANINE GREEN; BILIARY DRAINAGE; INTENSIVE-CARE;
D O I
10.1186/cc11381
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
During sepsis, the liver plays a key role. It is implicated in the host response, participating in the clearance of the infectious agents/products. Sepsis also induces liver damage through hemodynamic alterations or through direct or indirect assault on the hepatocytes or through both. Accordingly, liver dysfunction induced by sepsis is recognized as one of the components that contribute to the severity of the disease. Nevertheless, the incidence of liver dysfunction remains imprecise, probably because current diagnostic tools are lacking, notably those that can detect the early liver insult. In this review, we discuss the epidemiology, diagnostic tools, and impact on outcome as well as the pathophysiological aspects, including the cellular events and clinical picture leading to liver dysfunction. Finally, therapeutic considerations with regard to the weakness of the pertinent specific approach are examined.
引用
收藏
页数:8
相关论文
共 73 条
[1]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[3]   Catecholamines induce an inflammatory response in human hepatocytes [J].
Aninat, Caroline ;
Seguin, Philippe ;
Descheemaeker, Pierre-Neri ;
Morel, Fabrice ;
Malledant, Yannick ;
Guillouzo, Andre .
CRITICAL CARE MEDICINE, 2008, 36 (03) :848-854
[4]   Pathophysiology of increased intestinal permeability in obstructive jaundice [J].
Assimakopoulos, Stelios F. ;
Scopa, Chrisoula D. ;
Vagianos, Constantine E. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (48) :6458-6464
[5]  
AYALA A, 1993, ARCH SURG-CHICAGO, V128, P89
[6]  
Ayala A., 1993, ARCH SURG-CHICAGO, V128, P94
[7]   Administration of the nitric oxide synthase inhibitor NG-Methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis:: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002) [J].
Bakker, J ;
Grover, R ;
McLuckie, A ;
Holzapfel, L ;
Andersson, J ;
Lodato, R ;
Watson, D ;
Grossman, S ;
Donaldson, J ;
Takala, J .
CRITICAL CARE MEDICINE, 2004, 32 (01) :1-12
[8]   LIVER-FUNCTION IN SEPTIC SHOCK [J].
BANKS, JG ;
FOULIS, AK ;
LEDINGHAM, IM ;
MACSWEEN, RNM .
JOURNAL OF CLINICAL PATHOLOGY, 1982, 35 (11) :1249-1252
[9]   ET-1 INDUCED ALTERATIONS OF HEPATIC MICROCIRCULATION - SINUSOIDAL AND EXTRASINUSOIDAL SITES OF ACTION [J].
BAUER, M ;
ZHANG, JX ;
BAUER, I ;
CLEMENS, MG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (01) :G143-G149
[10]   Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study [J].
Blanco, Jesus ;
Muriel-Bombin, Arturo ;
Sagredo, Victor ;
Taboada, Francisco ;
Gandia, Francisco ;
Tamayo, Luis ;
Collado, Javier ;
Garcia-Labattut, Angel ;
Carriedo, Demetrio ;
Valledor, Manuel ;
De Frutos, Martin ;
Lopez, Maria-Jesus ;
Caballero, Ana ;
Guerra, Jose ;
Alvarez, Braulio ;
Mayo, Agustin ;
Villar, Jesus .
CRITICAL CARE, 2008, 12 (06)